The GroEL/GroES chaperonin system of Escherichia coli forms a nano-cage allowing single protein molecules to fold in isolation. However, as the chaperonin can also mediate folding independently of substrate encapsulation, it remained unclear whether the folding cage is essential in vivo. To address this question, we replaced wild-type GroEL with mutants of GroEL having either a reduced cage volume or altered charge properties of the cage wall. A stepwise reduction in cage size resulted in a gradual loss of cell viability, although the mutants bound non-native protein efficiently. Strikingly, a mild reduction in cage size increased the yield and the apparent rate of green fluorescent protein folding, consistent with the view that an effect of steric confinement can accelerate folding. As shown in vitro, the observed acceleration of folding was dependent on protein encapsulation by GroES but independent of GroES cycling regulated by the GroEL ATPase. Altering the net-negative charge of the GroEL cage wall also strongly affected chaperonin function. Based on these findings, the GroEL/GroES compartment is essential for protein folding in vivo.
Introduction
A subset of cytosolic proteins, including at least 13 essential proteins, are strictly dependent on the chaperonin GroEL and its co-factor GroES for folding (Kerner et al, 2005) . This likely explains why GroEL and GroES are essential for growth of E. coli (Fayet et al, 1989) . Based on mechanistic studies in vitro, GroEL and GroES form a nano-compartment for single protein molecules to fold unimpaired by aggregation (Mayhew et al, 1996; Weissman et al, 1996) . Moreover, recent experimental and theoretical studies provided evidence that transient enclosure of unfolded protein in the chaperonin cage may alter the folding energy landscape, resulting in accelerated folding for some proteins (Brinker et al, 2001; Baumketner et al, 2003; Takagi et al, 2003; Tang et al, 2006; Lucent et al, 2007) . However, as GroEL/GroES also assists protein folding by a binding-and-release mechanism that is independent of encapsulation, it has remained unclear whether the chaperonin cage is essential in vivo (Chaudhuri et al, 2001; Paul et al, 2007) .
The GroEL/GroES system has been the subject of extensive structural and functional analysis (reviewed in Hartl and Hayer-Hartl, 2002; Horwich et al, 2007) . GroEL is an B800 kDa cylindrical complex consisting of two stacked heptameric rings of B57 kDa subunits. Each subunit of GroEL is composed of an equatorial ATPase domain, an apical domain and an intermediate hinge-like domain. The apical domains expose hydrophobic amino-acid residues towards the central cavity for the binding of non-native protein. GroES, a single heptameric ring of B10 kDa subunits, caps the substrate-bound ring of GroEL. This step is dependent on ATP binding to the interacting GroEL ring (cis-ring) and results in the displacement of bound substrate into an enclosed cage generally large enough for proteins up to B60 kDa. Importantly, upon binding of ATP and GroES, GroEL undergoes a dramatic conformational change resulting in an enlarged hydrophilic cavity with a net-negative charge of 42. Substrate protein is allowed to fold inside this cage for about 10 s, the time needed for the hydrolysis of the seven ATP bound in the GroEL cis-ring. Once hydrolysis is complete, ATP binding to the trans-ring causes the dissociation of GroES and release of the enclosed substrate. Incompletely folded protein is rapidly recaptured by an open GroEL ring for another folding attempt inside the cage. However, proteins that are too large to be encapsulated, such as yeast mitochondrial aconitase (82 kDa) and E. coli maltodextrin glucosidase (69 kDa), can nevertheless utilize GroEL for folding by cycling on the GroEL ring in trans to GroES (Chaudhuri et al, 2001; Paul et al, 2007) . Indeed, several proteins larger than 60 kDa were found to interact with GroEL/GroES complexes (Kerner et al, 2005) , suggesting that trans-folding may be used more widely . Since transfolding depends on the regulatory function by GroES, this mechanism could also explain the essential role of GroEL and GroES in cell physiology.
To determine whether folding by encapsulation is an essential element of chaperonin function in vivo, we tested a series of GroEL mutants with a reduced cavity size or altered cavity wall charge for their ability to functionally replace wild-type (WT)-GroEL. A stepwise reduction in cage size resulted in a gradual loss of cell viability. Mutant GroEL that was no longer able to encapsulate substrate failed to support cell growth, although protein binding and the ability to support trans-folding was preserved. Thus protein folding by the encapsulation mechanism is an essential function of the chaperonin system.
Results

Reducing GroEL cavity size and net charge results in loss of E. coli viability
To test whether substrate enclosure in the chaperonin cage is essential for folding in vivo, we made use of a series of GroEL mutants with gradually reduced cavity size and encapsulation capacity (Tang et al, 2006) . In these mutants, the flexible C-terminal [GGM] 4 repeat sequences (B1.3 kDa per GroEL subunit) that protrude from the equatorial GroEL domains into the central cavity are either deleted (EL-DC) or repeated up to four times (EL-2[GGM] 4 to EL-4[GGM] 4 ). This results in either the deletion of B9 kDa or the addition of upto B27 kDa mass per heptameric GroEL ring. The GroEL mutants were co-expressed with WT-GroES under IPTG control in an MC4100 E. coli strain, in which the chromosomal groE operon is under the tight control of the arabinose (P BAD ) promoter (Kerner et al, 2005) . IPTG induction leads to two to threefold higher chaperonin levels than expression under the endogenous groE promoter. Growth of this strain in the absence of arabinose is only observed when functional GroEL/GroES is expressed (Figure 1 ). Expression of WTGroEL alone in the absence of arabinose failed to support cell growth at 371C, confirming that both GroEL and GroES are indispensable (Fayet et al, 1989) . Mutants ELDC and EL-2[GGM] 4 , either lacking the disordered [GGM] 4 tails or having a tail duplication, complemented as efficiently as WT-GroEL/GroES (Figure 1 ). However, further reduction in cavity size resulted in a gradual loss of viability, with an estimated 10-and 1000-fold drop in cell numbers for mutants EL-3[GGM] 4 and EL-4[GGM] 4 , respectively (Figure 1 ). This effect was also observed at growth temperatures of 30 and 421C (data not shown).
Next, we tested the ability of GroEL mutants with a reduced negative net charge of the cis-cavity wall to functionally replace WT-GroEL. These mutants are impaired in the folding of specific model substrates in vitro but are active in folding other proteins; they are functional in substrate binding, GroES-mediated encapsulation and release (Tang et al, 2006) . In EL-NNQ, the cis-cavity net charge of À42 of WTGroEL is reduced to À21, due to the mutation of three negatively charged amino acids to neutral (D359N, D361N and E363Q) in each subunit of the heptameric GroEL rings. These changes did not impair the function of GroEL in vivo (Figure 1 ). However, EL-3N3Q, containing three additional negative-to-neutral mutations (E252Q, D253N, E255Q), failed to complement. Failure to support cell growth was also observed for EL-KKK2, in which three negatively charged amino acids are mutated to positive (D359K, D361K, E363K) ( Figure 1 ). Both, EL-3N3Q and EL-KKK2 have a cis-cavity net charge of 0.
The failure of the GroEL mutants with reduced cavity size or net-charge to support E. coli growth may have resulted from their inability to either encapsulate essential cytosolic proteins or to provide a physical cavity environment conducive to their folding, respectively. Alternatively, some of the mutations may have affected the ability of GroEL to capture non-native substrate or may have changed the allosteric properties of the GroEL ATPase (Yifrach and Horovitz, 2000) .
GroEL cavity mutants are functional in substrate binding
A series of experiments was conducted to explore the possible impact of the cavity mutations on the ability of GroEL to capture non-native proteins. We first tested the binding capacity of the GroEL cavity size-mutants in the absence of ATP in an in vitro aggregation prevention assay with mitochondrial rhodanese as a model substrate (Martin et al, 1991) . This protein aggregates rapidly upon dilution from denaturant, as followed by an increase in absorbance at 320 nm ( Figure 2A ). Although GroEL suppressed aggregation completely, a 5-25% residual aggregation was noted for the In vivo functionality of GroEL cavity-mutants. Constructs encoding the proteins indicated were transformed into E. coli MC4100 SC3 Kan R cells. Cells were grown in the presence of arabinose for expression of WT-GroEL/GroES. Serial dilutions corresponding to cell numbers indicated were plated on arabinose-containing plates for continued expression of WT-GroEL/GroES or IPTG-containing plates for expression of GroEL-mutants/GroES at 371C as described in Materials and methods. cavity size-mutants scaling with the length of the C-terminal extensions ( Figure 2A, left panel) . Doubling the concentration of chaperonin relative to rhodanese resulted in nearly complete suppression of aggregation ( Figure 2A , right panel). Fully efficient aggregation prevention was also observed for the cavity charge mutants (Supplementary Figure S1) .
As prevention of aggregation provides only a semi-quantitative measure of GroEL substrate affinity, substrate binding was analysed directly by testing the ability of the GroEL mutants to form binary complexes with proteins varying in size, including rhodanese (33 kDa), and the authentic GroEL substrates METK (S-adenosyl methionine synthetase; 42 kDa) and SYT (threonyl-tRNA synthetase; 74 kDa) of E. coli (Kerner et al, 2005) . Denatured proteins were diluted into buffer solution containing an equimolar concentration of either WT-GroEL, EL-2[GGM] 4 or EL-4[GGM] 4 , followed by size-exclusion chromatography. Efficient complex formation with mutant GroEL was observed with all substrates tested, whereas aggregated proteins formed in the absence of GroEL were not recovered from the sizing column (data not shown). The ability of EL-2[GGM] 4 to capture the unfolded proteins was reduced by 1-5% and that of EL-4[GGM] 4 by 9-25% relative to WT-GroEL ( Figure 2B ). The slightly earlier elution of substrate complexes with EL-4[GGM] 4 , which was most pronounced with SYT (74 kDa), may suggest that the bound substrate protrudes from the smaller cavity more than in the case of WT-GroEL or EL-2[GGM] 4 .
As an additional measure of substrate binding, we tested the capacity of the GroEL mutants to inhibit the spontaneous refolding of maltose-binding protein (MBP) upon dilution from denaturant. The GroEL and single-ring (SR)-EL cavitysize-mutants up to 3[GGM] 4 showed nearly WT efficiency in To assess the functionality of the GroEL cavity-mutants in substrate binding and GroES cycling in vivo, we analysed their ability to support protein folding without encapsulation by the so-called trans-mechanism. In this mechanism, substrates such as yeast aconitase (82 kDa) fold by cycling on the GroEL ring in trans to GroES (Chaudhuri et al, 2001) . Upon expression of yeast aconitase in E. coli, only B17% of the protein was recovered in the soluble fraction ( Figure 2C , lanes 1-3). Whereas co-expression of WT-GroEL alone did not improve the folding yield, co-expression of both GroEL and GroES increased the yield of soluble aconitase to B39% ( Figure 2C , lanes 4-6 and 10-12), consistent with the GroES dependence of trans-folding (Chaudhuri et al, 2001) . The GroEL cavity size-and charge-mutants all enhanced the yield of soluble aconitase to the same extent ( Figure 2C , lanes 7-30), confirming that they are functional in substrate binding and ATP-dependent GroES cycling in vivo.
The results from the in vitro binding analyses and the functional in vivo assays demonstrate that the GroEL cavitymutants preserve the ability to bind and release non-native proteins. Thus, the failure of the size-mutant, EL-4[GGM] 4 , and the charge-mutants, EL-3N3Q and EL-KKK2, to replace WT-GroEL in vivo is probably due to their impaired ability to mediate folding of essential proteins by the encapsulation mechanism ( Figure 1 ).
GroEL size-mutants have a reduced capacity to encapsulate substrates in vivo
Most E. coli proteins that interact with GroEL for folding are smaller than 60 kDa in size and thus could be enclosed in the chaperonin cage (Kerner et al, 2005) . To test whether reducing the cavity volume limits the size range of substrates that can be encapsulated in vivo, we applied an established pulldown assay to isolate mutant-GroEL/GroES complexes with enclosed substrate from cell extracts. A His 6 -tagged version of GroES from Methanosarcina mazei (Mm) was transiently cooverexpressed with the GroEL size-mutants in E. coli MC4100 cells, expressing endogenous GroEL/GroES. MmGroES is fully functional in E. coli but results in a more stable interaction with GroEL, facilitating the isolation of complexes upon rapid conversion of ATP to ADP by glucose/hexokinase during cell lysis (Kerner et al, 2005) . Substrate proteins up to B60 kDa are enclosed in the isolated GroEL/MmGroES complexes ( Figure 3A) , protected against externally added protease (Kerner et al, 2005) .
No chaperonin complexes were isolated in the absence of 
Enhanced folding of GFP in a smaller GroEL cavity
Reducing the size of the GroEL/GroES cage may accelerate the folding of relatively small proteins (B30 kDa), due to 
Figure 3 Encapsulation efficiency of endogenous substrates by GroEL cavity size-mutants. (A) Schematic representation of complexes of GroEL with His 6 -tagged MmGroES arrested in the ADP state with substrate enclosed within the cis-cavity. (B) E. coli MC4100 cells overexpressing GroEL cavity size-mutants and His 6 -tagged MmGroES were lysed, and chaperonin complexes containing endogenous substrates were isolated as described in Materials and methods. The substrate proteins indicated were detected by immunoblotting. GroEL was detected with the anti-serum against XYLA, which has strong GroEL cross-reactivity. To control for specificity, the same isolation procedure was performed with cells overexpressing WT-GroEL and non-His 6 -tagged MmGroES.
steric confinement of folding intermediates (Hayer- Hartl and Minton, 2006; Tang et al, 2006) . If the chaperonin cavity has a critical role in folding, this effect may also lead to an increase in folding yield in vivo. To test this possibility, we chose WT green fluorescent protein (GFP; 27 kDa) as an aggregationprone model substrate (Wang et al, 2002) . Overexpression of WT-GroEL and GroES at 301C enhanced the solubility of GFP from 10 to 40% ( Figure 4A , lanes 2 and 8) and increased GFP fluorescence sevenfold ( Figure 4B ), consistent with previous findings (Wang et al, 2002) . Strikingly, co-overexpression with EL-2[GGM] 4 /GroES, which has a moderately reduced cavity size, improved the solubility of GFP to 60% ( Figure 4A , lane 11) and increased GFP fluorescence more than tenfold ( Figure 4B ). On the other hand, EL-3[GGM] 4 was less efficient than WT-GroEL, and EL-4[GGM] 4 was inactive in supporting GFP folding ( Figure 4A and B) . Deleting the C-terminal tails in EL-DC also markedly reduced folding yield ( Figure 4A , lane 5 and Figure 4B ). Refolding experiments in vitro, monitoring the gain in GFP fluorescence, were performed to investigate this effect in more detail. As GFP refolding is biphasic (Fukuda et al, 2000; Iwai et al, 2001 ), apparent folding rates are presented as the weighted average of fast and slow phases (B27 Â10
À3
and B5 Â10 À3 s À1 , respectively), based on their relative amplitudes. Spontaneous refolding of denatured GFP resulted in the recovery of B35% native protein ( Figure 4C ), as refolding was limited by aggregation. WT-GroEL/GroES and ATP increased the yield by B50% and accelerated folding approximately twofold ( Figure 4C and D Figure 6B ). In contrast to the observations in vivo ( Figure 4A and B), refolding with ELDC in vitro was similarly efficient as WT-GroEL ( Figure 4C and D). This discrepancy may be due to the coupling of folding and fluorophore formation in vivo, whereas the protein used for the in vitro experiments has a preformed fluorophore. These results demonstrate that the mutations changing the size of the GroEL cavity affect both the yield and rate of GFP folding. A moderate reduction in cavity size appears to be optimal for the folding of GFP, whereas further reduction is inhibitory, presumably restricting rearrangement necessary for folding.
Restriction of substrate motility in GroEL mutants with reduced cavity size Steady-state fluorescence anisotropy measurements with GFP (27 kDa) and a fusion protein of mouse dihydrofolate reductase and GFP (DHFR-GFP, B50 kDa) were performed to evaluate the effect of steric confinement by the chaperonin cage. GroES-mediated encapsulation of the proteins was performed in non-cycling single-ring (SR) versions of WTGroEL and cavity size-mutants. SR-EL is functionally similar to WT-GroEL, but undergoes only one round of ATP Figure 4 Enhanced folding of GFP upon mild reduction of GroEL cavity size. Solubility (A) and fluorescence (B) of WT-GFP upon cooverexpression with GroEL cavity size-mutants and GroES in E. coli MC4100 cells at 301C. Cells were grown and analysed as in Figure 2C (see Materials and methods). Total (T), supernatant (S) and pellet (P) fractions from equal amounts of cells were analysed by SDS-PAGE and Coomassie staining. GFP fluorescence was measured in cell lysates containing equal amounts of total protein with the activity in the vector only control set to 1. Standard deviations of at least three independent experiments are shown. (C) and (D) Kinetics and yield of GFP refolding with GroEL cavity size-mutants and GroES in vitro. Refolding yields are plotted with the native GFP control set to 1. Refolding traces were fitted to a double exponential equation and apparent rates are plotted as the weighted average of the slow and fast rates based on their relative amplitudes. Standard deviations of at least three independent experiments are shown. 0.8 Figure 6 Accelerated folding of GFP and rhodanese in cavity size-mutants is independent of ongoing ATP-hydrolysis. Kinetics and yield of WT-GFP refolding (A, B) and of rhodanese refolding (C, D) with SR-EL cavity size-mutants and GroES/ATP in vitro. Refolding yields are plotted with the native GFP and rhodanese control set to 1, respectively. Refolding traces for GFP were fitted as in Figure 4D and refolding traces for rhodanese were fitted to a single exponential equation. Note that there is essentially no spontaneous renaturation of rhodanese under the experimental conditions. Standard deviations of at least three independent experiments are shown.
hydrolysis, forming a stable complex with GroES and encapsulated substrate (Weissman et al, 1996) . Substantially higher anisotropy values were obtained for GFP upon enclosure in the stable cis-cavity than for the free native or spontaneously refolded protein ( Figure 5A) Figure 5B ). This suggests that GroES-mediated encapsulation of DHFR-GFP in SR-3[GGM] 4 and SR-4[GGM] 4 is no longer possible and that the protein is instead displaced from the chaperonin complex.
To address this possibility, we tested the accessibility of DHFR-GFP to proteinase K (PK), based on previous observations that substrate protein encapsulated in SR-EL by GroES is protease protected (Hayer-Hartl et al, 1996; Weissman et al, 1996) . Non-native DHFR-GFP bound to chaperonin in the absence of GroES was readily degraded, whereas encapsulation in SR-DC, SR-EL and SR-2[GGM] 4 resulted in complete protease protection ( Figure 5C and D) . In contrast, when bound to SR-3[GGM] 4 or SR-4[GGM] 4 , addition of GroES resulted in only 25-30% protease protection ( Figure 5C and D), indicating that stable encapsulation no longer occurred. The residual protease resistance may be due to the folding or misfolding of some DHFR-GFP upon its displacement from chaperonin.
Together, these results provide direct evidence that reducing cavity size effectively restricts the motility of the enclosed 27 kDa GFP. Whereas a mild reduction in cavity volume in the EL-2[GGM] 4 variant is associated with enhanced GFP folding (Figure 4) , the more marked volume reduction in EL-3[GGM] 4 results in the exclusion of substrate proteins of B35 kDa and greater (Figures 3 and 5) .
Relationship of folding rate and GroEL ATPase activity
The chaperonin cycle is allosterically regulated by ATP binding and hydrolysis (Yifrach and Horovitz, 2000) . GroES binds and unbinds from GroEL approximately every 10-15 s, the time needed for completion of ATP-hydrolysis in the GroEL cis-ring. GroES dissociation results in the release of enclosed substrate, with incompletely folded protein rapidly rebinding to an open GroEL ring. Many substrates interact with GroEL for several reaction cycles and it has been suggested that rebinding serves to repeatedly unfold kinetically trapped intermediates, thereby allowing faster folding speeds ('iterative annealing') (Thirumalai and Lorimer, 2001) . To test whether the acceleration of folding of B30 kDa proteins observed upon reducing GroEL cavity size is dependent on GroES cycling, we performed in vitro refolding experiments with SR-EL size-mutants, in which folding occurs upon a single round of encapsulation (Weissman et al, 1996) . Importantly, the rate acceleration of GFP folding observed with the cycling GroEL system ( Figure 4C and D) was reproduced with the non-cycling SR-EL size-mutants ( Figure  6A and B) . Again, optimal folding rate and yield was obtained with the 2[GGM] 4 size-mutant. Similarly, a folding rate acceleration of rhodanese (33 kDa) was observed with SR-EL-2[GGM] 4 /GroES (Figure 6C and D) . As under the experimental conditions, the SR-2[GGM] 4 /GroES complex encapsulates substrate stably ( Figure 5C and D) , the ability of this cavity size-mutant to enhance the folding kinetics of GFP and rhodanese is independent of iterative GroEL ATPase cycles. The use of SR-EL in these experiments also rules out possible effects of substrate or residual denaturant on the steady-state GroEL ATPase as the cause of accelerated folding.
It has also been suggested that an increase of the GroEL ATPase activity could contribute to the effects on folding rate observed with the GroEL size-mutants by altering the dwell time of substrate in the cis-cavity . ATPase measurements showed that extension of the C-terminal GroEL sequences results in a two-to threefold increase of the maximal GroEL ATPase activity, dependent on assay conditions ( Figure 7A and Supplementary Figure S4) . However, the ATPase activity did not increase linearly with the length of the C-terminal extensions, as reported by Farr et al (2007) , but rather reached a plateau with the 2[GGM] 4 mutant. Importantly, the ability of GroES to inhibit the ATPase activity by B50% was preserved. The dependence of ATPase activity on ATP concentration was similar for WTGroEL and GroEL tail extension-mutants, with half-maximal rates being observed at 6-12 mM ATP (Supplementary Figure  S4) . As the tail extension-mutants have similar ATPase activities, the decrease in folding rate and yield observed with EL- Figure 4 ) is unrelated to the ATPase activation but is rather a consequence of the reduction of cis-cavity size. Although, in the case of EL-2[GGM] 4 , the enhanced ATPase may have increased substrate turnover and thus the yield of GFP refolding in vivo ( Figure 4A and B) (Tehver and Thirumalai, 2008) , it is likely that the reduced cavity size contributed to this effect. This is supported by our observation with SR-2[GGM] 4 in which folding rate is independent of ongoing ATP hydrolysis ( Figure 6 ).
3[GGM] 4 and EL-4[GGM] 4 relative to EL-2[GGM] 4 (
To test whether the activation of the GroEL ATPase affects the folding rate upon a single round of encapsulation, we generated GroEL cavity size-mutants containing the additional mutation D398A in the ATPase domain. GroEL(D398A) binds ATP and GroES but hydrolyzes ATP extremely slowly (Rye et al, 1997) . As a result, substrate encapsulation and folding occurs upon single-round encapsulation as in SR-EL, but with very slow ATP-hydrolysis. As expected, GroEL(D398A), EL-2[GGM] 4 (D398A) and EL-3[GGM] 4 (D398A) had negligible ATP-hydrolysis rates of B2% of WT-GroEL ( Figure 7B ). The rate and yield of GFP folding with GroEL(D398A) was reduced by B25% compared with WT-GroEL. Importantly, EL-2[GGM] 4 (D398A) resulted in an B50% increase in folding rate and yield relative to GroEL(D398A). This effect was reversed with EL-3[GGM] 4 (D398A) (Figure 7C ), reproducing the results observed with the GroEL and SR-EL tail extension-mutants ( Figures 4D and 6B) . Similar results were obtained with rhodanese. Again folding was accelerated with EL-2[GGM] 4 (D398A) and slowed with EL-3[GGM] 4 (D398A) ( Figure 7D) .
These experiments failed to demonstrate a dependence of folding rate on the GroEL ATPase over a range of ATPase activities from close to 0 to B3-fold higher than WT, both in the cycling and non-cycling systems. This is consistent with a theoretical simulation of rhodanese folding during GroEL/ GroES cycling. In this simulation, GroEL is in excess over protein substrate, such that essentially all non-native protein is GroEL associated. Folding is assumed to occur only upon protein encapsulation in the GroEL/GroES cage, at a rate equivalent to spontaneous folding (Brinker et al, 2001) . A two-to fivefold increase in steady-state ATPase is predicted to have little effect on folding rate, whereas a further rate increase begins to slow folding due to the reduction of the dwell time of rhodanese in the cis-cavity and a corresponding increase of the dwell time in the GroEL-bound state ( Figure 7E and Supplementary Figure S5 ). Reducing the ATPase activity has no effect on folding rate, consistent with the finding that a single round of encapsulation by SR-EL results in fully efficient folding.
Discussion
Essential role of GroEL/GroES as a folding compartment The GroEL/GroES chaperonin system functions as a protein folding cage based on experiments in vitro (Mayhew et al, 1996; Weissman et al, 1996) , but whether folding by encapsulation underlies the essentiality of GroEL and GroES for E. coli growth (Fayet et al, 1989) had remained unclear. To determine whether the chaperonin cavity is dispensable for E. coli growth, we tested the in vivo functionality of GroEL mutants displaying modified cavity properties. GroEL versions with a reduced cavity size, precluding efficient encapsulation of substrates greater than B30 kDa, were no longer able to support E. coli growth. Likewise, removal of the net − GroES + GroES Figure 7 Accelerated folding by GroEL cavity size-mutants is independent of the rate of ATP hydrolysis. Steady-state ATPase activities of GroEL cavity size-mutants (A) and ATPase-deficient GroEL(D398A) cavity size-mutants (B) at 251C. ATPase rates are indicated in ATP hydrolyzed per GroEL tetradecamer per min (see Materials and methods). Refolding yields and rates of WT-GFP (C) and rhodanese (D) with GroEL(D398A) cavity size-mutants and GroES/ATP. Refolding traces for GFP were fitted as in Figure 4D and refolding traces for rhodanese were fitted to a single exponential equation. The refolding yield obtained with WT-GroEL/GroES was set to 1. Standard deviations of at least three independent experiments are shown. (E) Simulation of rhodanese folding kinetics dependent on GroEL/GroES cycling rate at excess chaperonin over substrate. The binding rate of unfolded protein to GroEL was set to 2 Â10 7 M À1 s À1 (Rye et al, 1999) and binding of GroES to GroEL-substrate complexes was set to 1 Â10 6 M À1 s À1 (KC and SS, unpublished data, 2007) . The rate of rhodanese refolding with WT-GroEL/GroES or SR-EL/ GroES was set to 2.5 Â10 À3 s À1 ( Figure 7D ). The normal ATPase-induced cycling rate was fixed at 0.07 s À1 with an approximate half-time of 10 s. The simulation was performed using chemical kinetics simulator (CKS) (http://www.almaden.ibm.com/st/computational_science/ck). The ATPase-induced cycling rate was varied between 0.1-and 20-fold of the normal rate and refolding rates are plotted. The concentrations used for the simulation were GroEL 1 mM, GroES 2 mM and rhodanese 0.5 mM (see Supplementary Figure S5 for a kinetic model for the simulation).
negative charge of the cis-cavity wall resulted in loss of GroEL function. Importantly, these mutants preserved the ability to bind and release non-native substrate protein and GroES. The 10-25% reduction in substrate-binding capacity of GroEL-3[GGM] 4 and 4[GGM] 4 cannot account for the failure of these variants to support normal growth when considering that E. coli tolerates an B90% reduction in GroEL levels without significant growth impairment (McLennan et al, 1993; Kerner et al, 2005) . Thus, our findings demonstrate the essential role of the chaperonin compartment in protein folding in vivo. The GroEL/GroES folding cage probably provides its essential function by preventing protein aggregation during folding and by reducing kinetic folding barriers encountered by a subset of substrates.
Significance of GroEL cavity size and charge
The volume capacity of the GroEL/GroES cage is generally sufficient for proteins up to B60 kDa. A special case is the encapsulation of an B86 kDa assembly intermediate of the heterodimeric mitochondrial branched-chain a-ketoacid dehydrogenase, consisting of B50.7 and B35.5 kDa subunits (Chen et al, 2006) . On the other hand, single protein molecules of B69 and B74 kDa cannot be encapsulated (Kerner et al, 2005; Paul et al, 2007 ). An additional mass of B18 kDa per GroEL ring generated by triplicating the C-terminal [GGM] 4 repeat sequences in mutant EL-3[GGM] 4 resulted in a 10-fold drop in cell number in the absence of WT-GroEL. EL-4[GGM] 4 , having an added mass of B27 kDa per GroEL ring, was essentially unable to support E. coli growth (B1000-fold drop in cell number upon loss of WT-GroEL). Analysis of isolated chaperonin complexes showed that EL-3[GGM] 4 partially or completely excludes proteins greater than B35 kDa and EL-4[GGM] 4 proteins greater than B30 kDa. Consistent with these findings, the majority of GroEL-dependent E. coli proteins are between B20 and 50 kDa, with six of the 13 substrates predicted to have essential function exceeding B31 kDa in size (Kerner et al, 2005) . Thus, the failure of EL-4[GGM] 4 to support E. coli growth can be explained by the exclusion of these essential proteins from the GroEL/GroES cage, resulting in their misfolding. The capacity of EL-2[GGM] 4 to replace WT-GroEL is consistent with the ability of this mutant to encapsulate proteins up to at least B40 kDa (Tang et al, 2006 and this study); this would include all essential E. coli proteins predicted to be GroEL dependent, with the exception of D-amino acid dehydrogenase (B48 kDa) and topoisomerase IV (PARC, B84 kDa) (Kerner et al, 2005) . Notably, PARC is too large to be encapsulated even by WT-GroEL and may follow the trans-folding mechanism described for yeast aconitase (Chaudhuri et al, 2001) .
As demonstrated with EL-2[GGM] 4 , moderately restricting cavity space can accelerate the folding of proteins of B30 kDa, such as GFP, resulting in substantially higher folding yields in vivo. Various mechanistic components may contribute to enhancing folding speed, including an effect of steric confinement, which would entropically destabilize the unfolded state and favor the formation of compact folded protein (Baumketner et al, 2003; Takagi et al, 2003) . Anisotropy measurements provided direct evidence that multiplication of the C-terminal GroEL sequences restricts the motility of substrate protein upon encapsulation. For proteins of B30 kDa (GFP and rhodanese), encapsulation in EL-2[GGM] 4 results in productive confinement, whereas restricting motility further is inhibitory, presumably by hindering necessary rearrangement steps.
Independent evidence for the essential role of the chaperonin folding compartment was provided by our analysis of GroEL mutants with altered charge properties of the cavity wall. The inner surface of the GroEL ring exposes numerous positively and negatively charged amino-acid residues with a marked net negative charge of 42 (minus 6 per GroEL subunit). Many of the negatively charged residues are highly conserved among GroEL homologues (Brocchieri and Karlin, 2000) . Whereas GroEL mutant EL-NNQ, having a reduced net charge of minus 21, fully supported E. coli growth, the complete removal of the negative net charge in EL-3N3Q or EL-KKK2 resulted in the loss of in vivo functionality. In contrast, these GroEL charge-mutants were unaffected in their ability to support the soluble expression of the transfolding substrate aconitase. These results suggest that the negative charge property of the cavity is critical in the folding of some essential proteins by the encapsulation mechanism. The majority of GroEL-dependent E. coli proteins, including eight essential proteins, are negatively charged (pI values of 5.1-6.2) (Kerner et al, 2005) and thus could experience a repulsive force from the cavity wall that may facilitate folding. Such an effect may benefit many GroEL substrates, but it has also been shown that changing a single cavity-exposed aromatic residue on GroES to arginine (Y71R) can significantly improve the folding of a specific protein, GFP (Wang et al, 2002) . This finding, together with our present results, suggests that a mutual adaptation of the physical properties of the chaperonin cavity and the natural GroEL substrate complement has occurred during evolution.
Folding rate acceleration and ATPase turnover
There are currently two models for acceleration of folding by the GroEL/GroES system. Although mechanistically distinct, these two models are not mutually exclusive. The central element of the 'iterative annealing' hypothesis suggests that the GroES-mediated movement of the apical GroEL domains exerts a stretching force on bound substrate protein, thereby actively unfolding kinetically trapped, misfolded intermediates (Thirumalai and Lorimer, 2001 ). This effect, occurring in every chaperonin ATPase cycle, would speed up folding by reducing the half-life of slow folding species and allowing their repartitioning with kinetically more effective folding routes. In contrast, 'cage-mediated annealing' (Tang et al, 2006) posits that the physical environment of the chaperonin cavity is critical in enhancing folding speed. To distinguish between these two models, we explored the dependence of folding rate on GroEL ATPase activity for GFP and rhodanese. Specifically, we tested the premise of the iterative annealing model that a faster ATPase rate, as observed in the GroEL size-mutants, would speed up folding by increasing the number of potential unfolding events. Contrary to this assumption, we found that the folding rates achieved with the cycling GroEL/GroES and the non-cycling SR-EL/GroES systems are identical within experimental error. Importantly, the rate enhancement of folding achieved by reducing the size of the cis-cavity is also observed with SR-EL/GroES and is thus independent of the ATPase acceleration.
In the presence of GroES, SR-EL carries out a single round of ATP-hydrolysis and then becomes arrested in the ADP state (Weissman et al, 1996) . To test whether the rate of this In vitro refolding assays Green fluorescent protein (25 mM) was denatured in 20 mM Tris, pH 7.5, 20 mM KCl, 6 M GuHCl and refolded upon 100-fold dilution into buffer A or buffer B in the absence or presence of GroEL (0.5 mM) or SR-EL (1 mM) as described in the figure legends. Chaperoninassisted refolding was initiated by the addition of GroES (a twofold molar excess over GroEL or SR-EL) and 5 mM ATP at 251C. GFP fluorescence was monitored on a Fluorolog 3 Spectrofluorometer (Spex) as described above.
Rhodanese (50 mM) was denatured in denaturation buffer and refolded upon 100-fold dilution into buffer A or buffer B supplemented with chaperones as indicated in the figure legends and folding was initiated as above. Refolding was stopped at different times by the addition of 50 mM CDTA, followed by colorimetric rhodanese assay (Hayer-Hartl et al, 1996) .
ATPase assay GroEL (0.2 mM oligomer) was incubated in 20 mM Tris-HCl, pH 7.5, 200 mM KCl, 5 mM MgCl 2 for 5 min at 251C; when indicated, GroES was present at a twofold molar excess over GroEL. The reaction was initiated by the addition of 2 mM ATP. ATPase activities were followed for 0-20 min, with time points taken every 2.5 min. Reactions were stopped by the addition of 15 mM CDTA. Quantification of liberated inorganic phosphate was measured by the malachite green assay (Lanzetta et al, 1979) .
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